Explain this page
Arphra AIPlain-English read on Aditxt, Inc.’s valuationAI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
—
— vs spot
Recommendation
n/a
0 of 0 methods
Method spread
0bull0bear
±5% threshold
Analyst PT consensus: $1,280.00 (+6736742.11%)
Price change · trailing returns
Live| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -34.26% | -72.46% | -99.41% | -99.97% | -100.00% | -99.99% | -100.00% | -100.00% | -100.00% | -100.00% | -100.00% |
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Aftermarket
LiveLast trade
$0.02
1 sh
Bid
$0.02
100 sh
Ask
$0.02
100 sh
Spread
$0.001
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Communication Services+2.03%
- Energy+1.52%
- Financial Services+0.66%
- Consumer Defensive+0.59%
- Technology+0.35%
- Real Estate+0.18%
- Consumer Cyclical-0.78%
- Healthcare-0.93%
- Basic Materials-1.17%
- Utilities-2.16%
- Industrials-2.50%
Top industries (issuer's industry highlighted)
- Biotechnology+4.42%
- Engineering & Construction-4.00%
- Agricultural - Machinery-3.34%
- Oil & Gas Drilling+3.29%
- Internet Content & Information+3.13%
- Renewable Utilities-2.86%
- Travel Services-2.79%
- Oil & Gas Refining & Marketing+2.71%
- Electrical Equipment & Parts-2.69%
- Independent Power Producers-2.61%
- Construction Materials-2.56%
- Software - Infrastructure+2.56%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_items- Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Millionbusinesswire.com·Jun 09, 2026
- Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Millionbusinesswire.com·Jun 09, 2026
- Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selectionbusinesswire.com·Jun 08, 2026
- Ignite Proteomics Announces Prospective 10,000-Patient Oncology Registry to Evaluate Functional Proteomics in Cancer Therapy Selectionbusinesswire.com·Jun 08, 2026
Peers
No peer list available for ADTX.
Total assets
—
Total debt
—
Cash & equiv
—
Operating CF
—
Free cash flow
—
Buybacks
—
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|